Gene Expression Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Process, By Product, By Capacity, By Application, By Technique, By Region and Competition, 2020-2030F

Description

The Global Gene Expression Market, valued at USD 15.78 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 21.86 Billion by 2030. Gene expression delineates the fundamental cellular process whereby genetic information from DNA is converted into functional gene products, primarily proteins or RNA molecules, thereby dictating specific cellular attributes and functions. The market's expansion is significantly propelled by continuous advancements in genomic research and sequencing technologies, the escalating global incidence of chronic and infectious diseases necessitating precise diagnostic and prognostic tools, and growing investments in biopharmaceutical research and development for novel therapeutic discovery.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 15.78 Billion
Market Size 2030	USD 21.86 Billion
CAGR 2025-2030	5.58%
Fastest Growing Segment	Kits & Reagents
Largest Market	North America

Key Market Drivers

The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.

Key Market Challenges

A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.

Key Market Trends

The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.

Key Market Players

Catalent, Inc.
Quest Diagnostics Incorporated
F. Hoffmann-La Roche Ltd
Illumina, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Promega Corporation
Luminex Corporation
Takara Bio USA, Inc.
Danaher Corporation

Report Scope:

In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Market, By Process:

Sample Collection
Purification
cDNA synthesis & conversion
PCR Analysis
Data analysis & interpretation

Gene Expression Market, By Product:

Kits & Reagents
DNA Chips
Others

Gene Expression Market, By Capacity:

Low- to Mid- Plex
High-Plex

Gene Expression Market, By Application:

Drug Discovery & Development
Clinical Diagnostics
Biotech & Microbiology
Others

Gene Expression Market, By Technique:

RNA Expression
Promoter Analysis
Protein Expression& Posttranslational Modification Analysis

Gene Expression Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.

Available Customizations:

Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Expression Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
- 5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
- 5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
- 5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
- 5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
- 5.2.6. By Region
- 5.2.7. By Company (2024)
5.3. Market Map

6. North America Gene Expression Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Process
- 6.2.2. By Product
- 6.2.3. By Capacity
- 6.2.4. By Application
- 6.2.5. By Technique
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Gene Expression Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Process
    - 6.3.1.2.2. By Product
    - 6.3.1.2.3. By Capacity
    - 6.3.1.2.4. By Application
    - 6.3.1.2.5. By Technique
- 6.3.2. Canada Gene Expression Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Process
    - 6.3.2.2.2. By Product
    - 6.3.2.2.3. By Capacity
    - 6.3.2.2.4. By Application
    - 6.3.2.2.5. By Technique
- 6.3.3. Mexico Gene Expression Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Process
    - 6.3.3.2.2. By Product
    - 6.3.3.2.3. By Capacity
    - 6.3.3.2.4. By Application
    - 6.3.3.2.5. By Technique

7. Europe Gene Expression Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Process
- 7.2.2. By Product
- 7.2.3. By Capacity
- 7.2.4. By Application
- 7.2.5. By Technique
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Gene Expression Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Process
    - 7.3.1.2.2. By Product
    - 7.3.1.2.3. By Capacity
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By Technique
- 7.3.2. France Gene Expression Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Process
    - 7.3.2.2.2. By Product
    - 7.3.2.2.3. By Capacity
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By Technique
- 7.3.3. United Kingdom Gene Expression Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Process
    - 7.3.3.2.2. By Product
    - 7.3.3.2.3. By Capacity
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By Technique
- 7.3.4. Italy Gene Expression Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Process
    - 7.3.4.2.2. By Product
    - 7.3.4.2.3. By Capacity
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By Technique
- 7.3.5. Spain Gene Expression Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Process
    - 7.3.5.2.2. By Product
    - 7.3.5.2.3. By Capacity
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By Technique

8. Asia Pacific Gene Expression Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Process
- 8.2.2. By Product
- 8.2.3. By Capacity
- 8.2.4. By Application
- 8.2.5. By Technique
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Gene Expression Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Process
    - 8.3.1.2.2. By Product
    - 8.3.1.2.3. By Capacity
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By Technique
- 8.3.2. India Gene Expression Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Process
    - 8.3.2.2.2. By Product
    - 8.3.2.2.3. By Capacity
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By Technique
- 8.3.3. Japan Gene Expression Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Process
    - 8.3.3.2.2. By Product
    - 8.3.3.2.3. By Capacity
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By Technique
- 8.3.4. South Korea Gene Expression Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Process
    - 8.3.4.2.2. By Product
    - 8.3.4.2.3. By Capacity
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By Technique
- 8.3.5. Australia Gene Expression Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Process
    - 8.3.5.2.2. By Product
    - 8.3.5.2.3. By Capacity
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By Technique

9. Middle East & Africa Gene Expression Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Process
- 9.2.2. By Product
- 9.2.3. By Capacity
- 9.2.4. By Application
- 9.2.5. By Technique
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Gene Expression Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Process
    - 9.3.1.2.2. By Product
    - 9.3.1.2.3. By Capacity
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By Technique
- 9.3.2. UAE Gene Expression Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Process
    - 9.3.2.2.2. By Product
    - 9.3.2.2.3. By Capacity
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By Technique
- 9.3.3. South Africa Gene Expression Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Process
    - 9.3.3.2.2. By Product
    - 9.3.3.2.3. By Capacity
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By Technique

10. South America Gene Expression Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Process
- 10.2.2. By Product
- 10.2.3. By Capacity
- 10.2.4. By Application
- 10.2.5. By Technique
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Gene Expression Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Process
    - 10.3.1.2.2. By Product
    - 10.3.1.2.3. By Capacity
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By Technique
- 10.3.2. Colombia Gene Expression Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Process
    - 10.3.2.2.2. By Product
    - 10.3.2.2.3. By Capacity
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By Technique
- 10.3.3. Argentina Gene Expression Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Process
    - 10.3.3.2.2. By Product
    - 10.3.3.2.3. By Capacity
    - 10.3.3.2.4. By Application
    - 10.3.3.2.5. By Technique

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Gene Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Catalent, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Quest Diagnostics Incorporated
15.3. F. Hoffmann-La Roche Ltd
15.4. Illumina, Inc.
15.5. PerkinElmer, Inc.
15.6. Thermo Fisher Scientific, Inc.
15.7. Promega Corporation
15.8. Luminex Corporation
15.9. Takara Bio USA, Inc.
15.10. Danaher Corporation